| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1032859475 |
| P356 | DOI | 10.1038/SJ.CGT.7701090 |
| P698 | PubMed publication ID | 17885676 |
| P5875 | ResearchGate publication ID | 5956943 |
| P2093 | author name string | Bache M | |
| Taubert H | |||
| Trott KR | |||
| Bartel F | |||
| Kappler M | |||
| Hänsgen G | |||
| Dellas K | |||
| Greither T | |||
| Rot S | |||
| P2860 | cites work | Survivin is required for stable checkpoint activation in taxol-treated HeLa cells | Q44463996 |
| Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. | Q50335767 | ||
| Differential subcellular localization of functionally divergent survivin splice variants. | Q53384616 | ||
| Survivin as a radioresistance factor in pancreatic cancer. | Q54957784 | ||
| A role for survivin in radioresistance of pancreatic cancer cells. | Q55097726 | ||
| Spontaneous and radiation-induced apoptosis in colorectal carcinoma cells with different intrinsic radiosensitivities: survivin as a radioresistance factor | Q73166839 | ||
| Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus | Q73421746 | ||
| The influence of autologous tumor fibroblasts on the radiosensitivity of squamous cell carcinoma megacolonies | Q73793690 | ||
| Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells | Q79964476 | ||
| Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype | Q24290530 | ||
| Molecular analysis of survivin isoforms: evidence that alternatively spliced variants do not play a role in mitosis | Q24295217 | ||
| HBXIP functions as a cofactor of survivin in apoptosis suppression | Q24303423 | ||
| Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension | Q24305061 | ||
| Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies | Q24802579 | ||
| Expression of hypoxia-inducible factor (HIF)-1alpha as a biomarker of outcome in soft-tissue sarcomas | Q27851402 | ||
| Validating survivin as a cancer therapeutic target | Q28201382 | ||
| Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway | Q28215330 | ||
| Targeted therapy by disabling crossroad signaling networks: the survivin paradigm | Q28302751 | ||
| Survivin splice variants regulate the balance between proliferation and cell death | Q28305497 | ||
| The Survivin saga goes in vivo | Q28360685 | ||
| Survivin protein expression and hypoxia in advanced cervical carcinoma of patients treated by radiotherapy | Q30319986 | ||
| Elevated expression of survivin-splice variants predicts a poor outcome for soft-tissue sarcomas patients | Q30320243 | ||
| Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression | Q35094456 | ||
| Tumor-specific gene expression using the survivin promoter is further increased by hypoxia | Q35184871 | ||
| Survivin study: what is the next wave? | Q35207271 | ||
| Control of apoptosis during angiogenesis by survivin expression in endothelial cells | Q35745355 | ||
| Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. | Q35842152 | ||
| Role of survivin and its splice variants in tumorigenesis | Q35990300 | ||
| Survivin study: an update of "what is the next wave"? | Q36430244 | ||
| Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations | Q36622927 | ||
| Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. | Q37574259 | ||
| Effect of antisense hypoxia-inducible factor 1alpha on progression, metastasis, and chemosensitivity of pancreatic cancer | Q40289636 | ||
| Glioma cells under hypoxic conditions block the brain microvascular endothelial cell death induced by serum starvation | Q40393532 | ||
| Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. | Q40414453 | ||
| An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy | Q40521478 | ||
| Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms | Q40522890 | ||
| Survivin as a therapeutic target for radiation sensitization in lung cancer. | Q40566190 | ||
| Identification of a novel splice variant of the human anti-apoptopsis gene survivin | Q40596070 | ||
| Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53. | Q40596377 | ||
| Radiosensitization of human melanoma cells by ribozyme-mediated inhibition of survivin expression | Q40662443 | ||
| DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells | Q40703674 | ||
| Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit | Q40771423 | ||
| Pleiotropic cell-division defects and apoptosis induced by interference with survivin function | Q40913411 | ||
| Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth | Q42121132 | ||
| P433 | issue | 12 | |
| P304 | page(s) | 994-1001 | |
| P577 | publication date | 2007-09-21 | |
| P1433 | published in | Cancer Gene Therapy | Q15763088 |
| P1476 | title | The effects of knockdown of wild-type survivin, survivin-2B or survivin-delta3 on the radiosensitization in a soft tissue sarcoma cells in vitro under different oxygen conditions | |
| P478 | volume | 14 |
| Q38943486 | Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization. |
| Q35833369 | Betulinyl Sulfamates as Anticancer Agents and Radiosensitizers in Human Breast Cancer Cells |
| Q90284097 | Causes and Consequences of A Glutamine Induced Normoxic HIF1 Activity for the Tumor Metabolism |
| Q38863860 | Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma |
| Q30318543 | HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression |
| Q33630837 | Hypoxia-specific targets in cancer therapy: role of splice variants |
| Q37302745 | IAP-targeted therapies for cancer |
| Q38590667 | Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditions |
| Q39938298 | Normoxic accumulation of HIF1α is associated with glutaminolysis |
| Q52723384 | P4HA1: A single-gene surrogate of hypoxia signatures in oral squamous cell carcinoma patients. |
| Q42061215 | Statistical and radiobiological analysis of the so-called thyroid stunning |
| Q28273083 | Targeting survivin in cancer therapy |
Search more.